Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NMN in Patients Undergoing Cardiac Surgery
NCT07013591Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2026
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide mononucleotide in postoperative complications, sponsored by Brigham and Women's Hospital. Started Jun 2026; status: recruiting.
02
Drugs
nicotinamide mononucleotide
03
Conditions
postoperative complications
Beyond the preview
Go deeper on NCT07013591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07013591.